HOSPIRA 2004 LONG-TERM STOCK INCENTIVE PLAN RESTRICTED STOCK UNIT AGREEMENTRestricted Stock Unit Agreement • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations
This Restricted Stock Unit Agreement (the “Agreement”) is made between Hospira, Inc., a Delaware corporation (the “Company”), and the Participant specified below. The Agreement is subject to the provisions of the Hospira 2004 Long-Term Stock Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference.
HOSPIRA 2004 LONG-TERM STOCK INCENTIVE PLAN PERFORMANCE BASED RESTRICTED STOCK UNIT AGREEMENTPerformance Based Restricted Stock Unit Agreement • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations
This Performance Based Restricted Stock Unit Agreement (the “Agreement”) is made between Hospira, Inc., a Delaware corporation (the “Company”), and the Participant specified below. The Agreement is subject to the provisions of the Hospira 2004 Long-Term Stock Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference.
HOSPIRA 2004 LONG-TERM STOCK INCENTIVE PLAN NON-EMPLOYEE DIRECTOR RESTRICTED STOCK AGREEMENTNon-Employee Director Restricted Stock Agreement • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations
THIS AGREEMENT, entered into as of the Grant Date (as defined in paragraph 1), by and between the Director and Hospira (the “Company”);
AMENDMENT to BUSINESS TRANSFER AGREEMENTConfidential Treatment • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations
This Amendment (this “Amendment”) is made and entered into as of March 13, 2013, by and between Orchid Chemicals & Pharmaceuticals Ltd., a company incorporated under the Act (“Orchid”), and Hospira Healthcare India Private Limited, a company incorporated under the Act (“Hospira”), for the purpose of amending that certain Business Transfer Agreement, dated as of August 29, 2012, as amended, by and among Orchid, Mr. K. Raghavendra Rao and Hospira (as amended, the “Agreement”). Capitalized terms not defined herein shall have the meanings given to them in the Agreement.
AMENDMENT NO. 3 to BUSINESS TRANSFER AGREEMENTConfidential Treatment • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations
This Amendment No. 3 (this “Amendment”) is made and entered into as of March 13, 2013, by and between Orchid Chemicals & Pharmaceuticals Ltd., a company incorporated under the Act (“Orchid”), Mr. K. Raghavendra Rao (“KRR”) and Hospira Healthcare India Private Limited, a company incorporated under the Act (“Hospira”), for the purpose of amending that certain Business Transfer Agreement, dated as of August 29, 2012 (as amended), by and among Orchid, KRR and Hospira (as amended from time to time, the “Agreement”). Capitalized terms not defined herein shall have the meanings given to them in the Agreement.
AMENDMENT NO. 1 TO THE CREDIT AGREEMENTThe Credit Agreement • May 1st, 2013 • Hospira Inc • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO THE CREDIT AGREEMENT among HOSPIRA, INC., a Delaware corporation (the “Borrower”), the banks, financial institutions and other institutional lenders parties to the Credit Agreement referred to below (collectively, the “Lenders”) and Citibank, N.A., as administrative agent (the “Administrative Agent”) for the Lenders.
